Skip to main content

News and Announcements

Read the latest news from Northwestern University Feinberg School of Medicine’s Mesulam Center for Cognitive Neurology and Alzheimer's Disease. The links below take you to articles where you can learn more about our members' latest achievements, awards and honors.

  • 12.12.2024 NBC 5 Chicago
    On December 10, 2024, the Northwestern University Music and Medicine Program celebrated their milestone 10th Musical Museum concert, a musical and social engagement event, aiming to create a secure and enriching environment for individuals affected by Alzheimer's disease, related conditions, and their care partners. The event featured Dominika Zamara, renowned operatic vocalist, accompanied by Borna Bonakdarpour, pianist, cognitive neurologist, and director of the Music and Medicine Program.
  • 12.06.2024

    With a new $20 million grant from the National Institute on Aging, Northwestern Medicine investigator, Linda Teplin, PhD, is extending the work of the Northwestern Juvenile Project to study the long-term consequences of incarceration on age-related conditions, including Alzheimer’s and other age-related diseases. This project is the only large-scale longitudinal study of its kind tracking health and outcomes of detained juveniles in the years following their release.

  • 12.06.2024 CNN

    Music can bridge the gaps memory loss creates. Dr. Borna Bonakdarpour and the Northwestern Music and Medicine Program are studying how music can tap into the brain’s resilience, fostering connection and joy.

  • 12.05.2024

    A new study has found the more recently evolved and advanced parts of the human brain that support social interactions are in constant communication with an ancient part of the brain called the amygdala.

  • 11.07.2024 AARP

    Prioritizing social connections may be a powerful addition to the brain health checklist, says Dr. Tamar Gefen, assistant professor of psychiatry and behavioral sciences and co-director of the Northwestern University SuperAging Research Program (NUSAP). Research now shows that regular social engagement can help preserve brain volume, slow cognitive decline, and lower dementia risk in older adults, adding to the established benefits of healthy eating, exercise, and adequate sleep.

  • 11.05.2024 AFTD Webinar
    With primary progressive aphasia (PPA), problems with language and communication typically deteriorate gradually over time. Initial symptoms are sometimes attributed to anxiety or stress until the ongoing symptoms become disruptive enough to prompt further assessment by a specialist. Dr. Marsel Mesulam joined the AFTD to discuss how to diagnose PPA. 
  • 11.05.2024 Breakthroughs

    Borna Bonakdarpour, MD, is an associate professor of Neurology in the Division of Behavioral Neurology. His laboratory uses multimodal neuroimaging to study the underlying neural mechanisms of language impairment (aphasia) and impairment in other areas of cognition and use this information to develop and evaluate effective treatments for aphasia.

  • 11.05.2024

    Advocate Amy Bouschart traveled from Arizona to Chicago to receive a proclamation from Mayor Brandon Johnson, officially recognizing FTD Awareness Week in the city. Bouschart, whose husband Frank lives with frontotemporal degeneration (FTD), now hopes this recognition sparks further legislative action to improve healthcare access for those with early-onset diagnoses.

  • 10.24.2024 New York Times
    A recent investigation into Alzheimer’s drug trials reveals that some volunteers were not informed of their genetic predisposition to brain injuries, raising ethical concerns about informed consent. The Mesulam Center's Rudolph Castellani, MD, discussed with The New York Times his autopsy findings of a trial participant and the broader implications of transparency in clinical research.
  • 10.22.2024 Library of Congress
    In May 2024, Sandra Weintraub, PhD and Molly Mather, PhD, two Mesulam Center faculty members overseeing the Northwestern University SuperAging Program, joined the Library of Congress to discuss brain health, the effects of aging, and their research on SuperAging.
  • 10.16.2024 Research Renaissance

    In this enlightening episode of Research Renaissance, Deborah Westphal speaks with Dr. Robert Vassar, a renowned neuroscientist and Director of the Mesulam Center for Cognitive Neurology and Alzheimer's Disease at Northwestern University. Dr. Vassar shares his personal journey into the field of Alzheimer’s research, the evolution of diagnostic tools, and the latest technological breakthroughs in the fight against neurodegenerative diseases.

  • 10.02.2024 The Free Press
    “When we use musical intervention, we’re looking for areas and networks in the brain that are intact to serve as bridges and help the areas that are not working well. Singing, for example, can be a bridge to communicating better through language. The rhythmic nature of music can help people walk better.” Borna Bonakdarpour, MD, on using music to unlock memory.
  • 10.02.2024 Northwestern Magazine
    In an extraordinary study on aging, researchers at Northwestern University are uncovering what makes "SuperAgers" so unique. The Northwestern University SuperAging Program (NUSAP), now in its 25th year, combines cutting-edge science with personal connections, following participants through life and even after death.
  • 09.24.2024

    Feinberg principal investigators secured $742.2 million dollars in research funding and awards during the 2023-24 fiscal year, a five percent increase over the previous year, and the largest amount in the school’s history.

  • 09.20.2024 Northwestern Medicine
    Want to learn more about Alzheimer's and related dementias? Northwestern Medicine's Ian M. Grant, MD, behavioral neurologist, and Jennifer M. Woodward, MD, geriatrician answer some commonly asked questions.
  • 08.30.2024

    An international team of investigators have discovered that oligodendrocytes contribute approximately one-third of plaque formation alongside neurons in mouse models of Alzheimer’s disease, according to a recent study published in Nature Neuroscience.

    The post Non-Neuron Brain Cells Produce a Third of Amyloid Plaque in Alzheimer’s Disease appeared first on News Center.

  • 07.25.2024

    Northwestern Medicine scientists have discovered that mitochondria are not necessary for the proliferation of immune cells called microglia, but do help them respond to demyelinating injury, according to a study published in Nature Metabolism.

  • 07.18.2024 WebMD

    Discover how the brain can maintain health and functionality despite aging. Tamar Gefen, PhD, discusses insights into the remarkable resilience of SuperAgers and the Northwestern University SuperAging Program. Learn about the latest research on cognitive health and the factors contributing to exceptional memory retention and mental skills in older adults.

  • 07.11.2024 Chicago Sun Times

    SuperAger Edith Renfrow Smith is a rare “supercentenarian,” as she turns 110 on July 14. In the fall her alma mater, Grinell College, is naming a new dorm after her. Read her inspiring story!

  • 07.09.2024 CNN

    The Mesulam Center's Sandra Weintraub, PhD, joined CNN to discuss President Biden's cognitive health, highlighting the effects of aging and the importance of sleep and medical history on cognitive abilities

  • 06.27.2024

    Marking 25 years of groundbreaking research, the Northwestern University SuperAging Program (NUSAP) investigates SuperAgers—adults over 80 with memory abilities comparable to those 20 to 30 years younger. The program, pioneered by Sandra Weintraub, PhD, and Marsel Mesulam, MD, explores how these individuals defy normal cognitive aging.

  • 06.26.2024

    Northwestern investigators have identified a novel transcription factor which regulates a signaling mechanism utilized by a fertilized embryo to protect its mother from cellular and environmental stress, according to a recent study to published in the journal Genes and Development.

  • 06.10.2024 Yahoo Canada

    Joshua Cahan, MD, highlighted safety concerns with new anti-amyloid monoclonal antibodies, as FDA advisers meet to assess Eli Lilly's Alzheimer's drug, donanemab. This decision could shape future therapies for Alzheimer's patients.

  • 06.05.2024 Buzzfeed

    Experts, including the Mesulam Center's Tamar Gefen, PhD, highlight the unique qualities of "SuperAgers". While no specific trick ensures becoming a SuperAger, engaging in regular physical activity, maintaining social connections, and reducing stress are key practices observed among them.

  • 06.04.2024

    The Mesulam Center for Cognitive Neurology and Alzheimer’s Disease celebrated its 30th Annual Alzheimer’s Day on May 3, 2024, where researchers and community members came together to learn about recent accomplishments in the field, early-onset Alzheimer’s and community efforts raising awareness for those experiencing cognitive decline.

    The post Mesulam Center Celebrates 30th Annual Alzheimer Day appeared first on News Center.

  • 06.04.2024 Better Edge Podcast
    Borna Bonakdarpour, MD sat down with Northwestern Medicine's Better Edge podcast to discuss the highlights from the 2024 American Academy of Neurology (AAN) Annual Meeting. Dr. Bonakdarpour discusses leveraging the learnings from the meeting by incorporating the latest research and treatment approaches into patient care.
  • 06.03.2024

    The Mesulam Center for Cognitive Neurology and Alzheimer’s Disease celebrated its 30th Annual Alzheimer Day on May 3, 2024, where researchers and community members came together to learn about recent accomplishments in the field, early-onset Alzheimer’s and community efforts raising awareness for those experiencing cognitive decline. 

  • 05.18.2024

    For decades, Marcus Peter, PhD, has drilled into an area of research focused on cell death and the roles of toxic and protective short RNAs, with the goal of developing a novel form of cancer treatment. Now, this same line of research has led Peter’s team to uncover new insights into the cause of Alzheimer’s disease. In this episode, Peter explains his pioneering work in investigating RNA interference in diseases and explains how his lab’s latest novel discovery may have relevance to an array of neurodegenerative diseases beyond Alzheimer’s.

  • 05.15.2024 Research Renaissance
    Elena Barbieri recently sat down with the Research Renaissance podcast to discuss primary progressive aphasia (PPA), a rare neurological disorder progressively impairs the ability to speak and understand language while other cognitive functions remain relatively intact.

Follow Mesulam Center on Facebook